MarketCapTrends
AVTX
Avalo Therapeutics Inc. (AVTX)
NASDAQ · Healthcare

Avalo Therapeutics Inc. Cash on Hand 2015–2025

Avalo Therapeutics Inc. annual/quarterly cash on hand history from 2015 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.

  • Avalo Therapeutics Inc. cash on hand for the quarter ending December 31, 2025 were 15.9M, a 88.21% decrease year-over-year.
  • Avalo Therapeutics Inc. cash on hand for 2025 were 15.9M, a 88.21% decrease from 2024.
  • Avalo Therapeutics Inc. cash on hand for 2024 were 134.5M, a 1714.51% increase from 2023.
  • Avalo Therapeutics Inc. cash on hand for 2023 were 7.4M, a 43.71% decrease from 2022.
  • Avalo Therapeutics Inc. cash on hand for 2022 were 13.2M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Avalo Therapeutics Inc. Annual Cash on Hand (Millions of US $)
2025$16
2024$135
2023$7
2022$13
2021$55
2020$19
2019$4
2018$11
2017$2
2016$5
2015$21
Avalo Therapeutics Inc. Quarterly Cash on Hand (Millions of US $)
2025-12-31$16
2024-12-31$135
2023-12-31$7
2022-12-31$13
2021-12-31$55
2020-12-31$19
2019-12-31$4
2018-12-31$11
2017-12-31$2
2016-12-31$5
2015-12-31$21

Avalo Therapeutics Inc. Cash on Hand — FAQ

Avalo Therapeutics Inc. (AVTX) cash on hand over the last 11 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see AVTX's cash on hand history?

The chart and table above show Avalo Therapeutics Inc.'s cash on hand by year and by quarter, including the growth rate.